The CAR-NK cell product studied in this trial ... These therapeutic CAR-NK cells are made from induced pluripotent stem cells derived from healthy donor fibroblast cell lines with centralized ...

NK cell therapies can be made more quickly and at lower cost ... NK cells for potential therapies from induced pluripotent stem (iPS) cells — skin or blood cells that have been reprogrammed ...

However, a greater understanding of NK biology, coupled with the emergence of new technologies are leading to a resurgence of NK cell-based ... of induced pluripotent stem cells (iPSC) that ...

This means the type of cell obtained from an individual patient to make pluripotent stem cells, determines what can be best done with them. Scientists at McMaster University have discovered that ...

Researchers hope cells like these will eventually be used to treat heart failure. Credit: Xiaomeng Hu. UC San Francisco scientists have used the CRISPR-Cas9 gene-editing system to create the first ...

Transplanting genetically modified natural killer cells from iPS cells is the next big hope for anti-cancer therapies," concludes Niels-Bjarne Woods. "We just made producing natural killer cells ...

Human pluripotent ... donor cells show evidence of transformation), could be one fail-safe mechanism. The inclusion of additional molecules like HLA-G, which also binds inhibitory NK cell ...

Shoreline’s solution is to make its NK-cell and macrophage treatments from induced pluripotent stem cells, a renewable source of genetically identical cells. “As the leader in cell therapy ...

The ability to acquire high-quality NK cells in sufficient numbers represents a significant bottleneck in terms of NK cell application in adoptive immunotherapy. Induced pluripotent stem cells ...

Researchers have for the first time been able to generate a pluripotent stem cell line from the cells of a patient with a genetic disease, according to a study appearing tomorrow (August 1) in Science ...

One such intervention is stem cell ... pluripotent stem cells Scientists are researching several diseases and drug development applications for these cells, highlighting the characteristics that ...